The following criteria is provided for health care professionals.

Inclusion Criteria:

• Patients with confirmed diagnosis of active multiple myeloma (as defined by International Myeloma Working Group [IMWG] criteria) who have relapsed after prior lines of therapy.
• Eastern Cooperative Oncology Group Performance Status of 0 or 1;
• No previous treatment with investigational gene targeting CS1 or chimeric antigen receptor therapy targeting CS1
• Adequate organ function, including bone marrow, renal, hepatic, pulmonary, and cardiac function based on the last assessment performed within the screening period.
• Other criteria may apply